International
US experts discuss the freshly-approved Pfizer-BioNTech Covid-19 vaccine for 5-11 year-olds in a commentary, with parents and health teams in mind. While severe illness is lower in kids, they say as the disease spreads, the numbers of very unwell children will rise. Already in the States, more than 1.9 million 5-11 year-olds have been infected, and over 8300 hospitalised, a third of whom needed intensive care. The authors also report child hospitalisation is three times higher for Black, Hispanic, or Native American kids than for White kids.
From:
Pediatric COVID-19 Vaccines - What Parents, Practitioners, Policy Makers Need to Know
This Viewpoint discusses the FDA granting Emergency Use Authorization of the Pfizer-BioNTech mRNA COVID-19 vaccine for children ages 5 to 11 and the role that will play in keeping children, schools and communities safe.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
